The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Short Bowel Syndrome (SBS)-Global Market Insights and Sales Trends 2024
Synopsis
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
The global Short Bowel Syndrome (SBS) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Short Bowel Syndrome (SBS) in various end use industries. The expanding demands from the Hospitals, Clinics and Retail Pharmacies,, are propelling Short Bowel Syndrome (SBS) market. Oral Route, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parental Route segment is estimated at % CAGR for the next seven-year period.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Short Bowel Syndrome (SBS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Short Bowel Syndrome (SBS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Short Bowel Syndrome (SBS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Short Bowel Syndrome (SBS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Short Bowel Syndrome (SBS) covered in this report include Merck, Takeda, Emmaus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals and Zealand Pharma, etc.
The global Short Bowel Syndrome (SBS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Global Short Bowel Syndrome (SBS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Short Bowel Syndrome (SBS) market, Segment by Type:
Oral Route
Parental Route
Global Short Bowel Syndrome (SBS) market, by Sale Channel
Hospitals
Clinics
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Short Bowel Syndrome (SBS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
The global Short Bowel Syndrome (SBS) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Short Bowel Syndrome (SBS) in various end use industries. The expanding demands from the Hospitals, Clinics and Retail Pharmacies,, are propelling Short Bowel Syndrome (SBS) market. Oral Route, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parental Route segment is estimated at % CAGR for the next seven-year period.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Sale Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Short Bowel Syndrome (SBS), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Short Bowel Syndrome (SBS) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Short Bowel Syndrome (SBS) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Short Bowel Syndrome (SBS) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Short Bowel Syndrome (SBS) covered in this report include Merck, Takeda, Emmaus Medical, Ardelyx, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio Pharmaceuticals and Zealand Pharma, etc.
The global Short Bowel Syndrome (SBS) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Global Short Bowel Syndrome (SBS) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Short Bowel Syndrome (SBS) market, Segment by Type:
Oral Route
Parental Route
Global Short Bowel Syndrome (SBS) market, by Sale Channel
Hospitals
Clinics
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Short Bowel Syndrome (SBS) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Short Bowel Syndrome (SBS)
1.1 Short Bowel Syndrome (SBS) Market Overview
1.1.1 Short Bowel Syndrome (SBS) Product Scope
1.1.2 Short Bowel Syndrome (SBS) Market Status and Outlook
1.2 Global Short Bowel Syndrome (SBS) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Short Bowel Syndrome (SBS) Market Size by Region (2018-2029)
1.4 Global Short Bowel Syndrome (SBS) Historic Market Size by Region (2018-2023)
1.5 Global Short Bowel Syndrome (SBS) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Short Bowel Syndrome (SBS) Market Size (2018-2029)
1.6.1 North America Short Bowel Syndrome (SBS) Market Size (2018-2029)
1.6.2 Europe Short Bowel Syndrome (SBS) Market Size (2018-2029)
1.6.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size (2018-2029)
1.6.4 Latin America Short Bowel Syndrome (SBS) Market Size (2018-2029)
1.6.5 Middle East & Africa Short Bowel Syndrome (SBS) Market Size (2018-2029)
2 Short Bowel Syndrome (SBS) Market by Type
2.1 Introduction
2.1.1 Oral Route
2.1.2 Parental Route
2.2 Global Short Bowel Syndrome (SBS) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2018-2023)
2.2.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Short Bowel Syndrome (SBS) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Short Bowel Syndrome (SBS) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Short Bowel Syndrome (SBS) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Short Bowel Syndrome (SBS) Revenue Breakdown by Type (2018-2029)
3 Short Bowel Syndrome (SBS) Market Overview by Sale Channel
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Retail Pharmacies
3.2 Global Short Bowel Syndrome (SBS) Market Size by Sale Channel: 2018 VS 2022 VS 2029
3.2.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Sale Channel (2018-2023)
3.2.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Sale Channel (2024-2029)
3.3 Key Regions Market Size by Sale Channel
3.3.1 North America Short Bowel Syndrome (SBS) Revenue Breakdown by Sale Channel (2018-2029)
3.3.2 Europe Short Bowel Syndrome (SBS) Revenue Breakdown by Sale Channel (2018-2029)
3.3.3 Asia-Pacific Short Bowel Syndrome (SBS) Revenue Breakdown by Sale Channel (2018-2029)
3.3.4 Latin America Short Bowel Syndrome (SBS) Revenue Breakdown by Sale Channel (2018-2029)
3.3.5 Middle East and Africa Short Bowel Syndrome (SBS) Revenue Breakdown by Sale Channel (2018-2029)
4 Short Bowel Syndrome (SBS) Competition Analysis by Players
4.1 Global Short Bowel Syndrome (SBS) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) as of 2022)
4.3 Date of Key Players Enter into Short Bowel Syndrome (SBS) Market
4.4 Global Top Players Short Bowel Syndrome (SBS) Headquarters and Area Served
4.5 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
4.6 Competitive Status
4.6.1 Short Bowel Syndrome (SBS) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Short Bowel Syndrome (SBS) Products, Services and Solutions
5.1.4 Merck Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Takeda
5.2.1 Takeda Profile
5.2.2 Takeda Main Business
5.2.3 Takeda Short Bowel Syndrome (SBS) Products, Services and Solutions
5.2.4 Takeda Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.2.5 Takeda Recent Developments
5.3 Emmaus Medical
5.3.1 Emmaus Medical Profile
5.3.2 Emmaus Medical Main Business
5.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Products, Services and Solutions
5.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.3.5 Ardelyx Recent Developments
5.4 Ardelyx
5.4.1 Ardelyx Profile
5.4.2 Ardelyx Main Business
5.4.3 Ardelyx Short Bowel Syndrome (SBS) Products, Services and Solutions
5.4.4 Ardelyx Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.4.5 Ardelyx Recent Developments
5.5 Naia Pharmaceuticals
5.5.1 Naia Pharmaceuticals Profile
5.5.2 Naia Pharmaceuticals Main Business
5.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Products, Services and Solutions
5.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.5.5 Naia Pharmaceuticals Recent Developments
5.6 Nutrinia
5.6.1 Nutrinia Profile
5.6.2 Nutrinia Main Business
5.6.3 Nutrinia Short Bowel Syndrome (SBS) Products, Services and Solutions
5.6.4 Nutrinia Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.6.5 Nutrinia Recent Developments
5.7 OxThera
5.7.1 OxThera Profile
5.7.2 OxThera Main Business
5.7.3 OxThera Short Bowel Syndrome (SBS) Products, Services and Solutions
5.7.4 OxThera Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.7.5 OxThera Recent Developments
5.8 Sancilio Pharmaceuticals
5.8.1 Sancilio Pharmaceuticals Profile
5.8.2 Sancilio Pharmaceuticals Main Business
5.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Products, Services and Solutions
5.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.8.5 Sancilio Pharmaceuticals Recent Developments
5.9 Zealand Pharma
5.9.1 Zealand Pharma Profile
5.9.2 Zealand Pharma Main Business
5.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Products, Services and Solutions
5.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Revenue (US$ Million) & (2018-2023)
5.9.5 Zealand Pharma Recent Developments
6 North America
6.1 North America Short Bowel Syndrome (SBS) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Short Bowel Syndrome (SBS) Market Dynamics
11.1 Short Bowel Syndrome (SBS) Industry Trends
11.2 Short Bowel Syndrome (SBS) Market Drivers
11.3 Short Bowel Syndrome (SBS) Market Challenges
11.4 Short Bowel Syndrome (SBS) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
